Anthera Pharmaceuticals Inc (ANTH)
0.0001
0.00 (0.00%)
USD |
OTCM |
Nov 04, 16:00
Anthera Pharmaceuticals Max Drawdown (5Y): 100.0% for Sept. 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
September 30, 2024 | 100.0% |
August 31, 2024 | 100.0% |
July 31, 2024 | 100.0% |
June 30, 2024 | 100.0% |
May 31, 2024 | 100.0% |
April 30, 2024 | 100.0% |
March 31, 2024 | 100.0% |
February 29, 2024 | 100.0% |
January 31, 2024 | 100.0% |
December 31, 2023 | 100.0% |
November 30, 2023 | 100.0% |
October 31, 2023 | 100.0% |
September 30, 2023 | 100.0% |
August 31, 2023 | 100.0% |
July 31, 2023 | 100.0% |
June 30, 2023 | 100.0% |
May 31, 2023 | 100.0% |
April 30, 2023 | 100.0% |
March 31, 2023 | 100.0% |
February 28, 2023 | 100.0% |
January 31, 2023 | 100.0% |
December 31, 2022 | 100.0% |
November 30, 2022 | 100.0% |
October 31, 2022 | 100.0% |
September 30, 2022 | 100.0% |
Date | Value |
---|---|
August 31, 2022 | 100.0% |
July 31, 2022 | 100.0% |
June 30, 2022 | 100.0% |
May 31, 2022 | 100.0% |
April 30, 2022 | 100.0% |
March 31, 2022 | 100.0% |
February 28, 2022 | 100.0% |
January 31, 2022 | 100.0% |
December 31, 2021 | 100.0% |
November 30, 2021 | 100.0% |
October 31, 2021 | 100.0% |
September 30, 2021 | 100.00% |
August 31, 2021 | 99.98% |
July 31, 2021 | 99.98% |
June 30, 2021 | 99.98% |
May 31, 2021 | 99.98% |
April 30, 2021 | 99.98% |
March 31, 2021 | 99.98% |
February 28, 2021 | 99.98% |
January 31, 2021 | 99.98% |
December 31, 2020 | 99.98% |
November 30, 2020 | 99.98% |
October 31, 2020 | 99.98% |
September 30, 2020 | 99.98% |
August 31, 2020 | 99.98% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.97%
Minimum
Nov 2019
100.0%
Maximum
Oct 2021
99.99%
Average
100.0%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
Ampio Pharmaceuticals Inc | 100.0% |
FluoroPharma Medical Inc | 100.00% |
Evolutionary Genomics Inc | 99.96% |
Xeno Transplants Corp | 100.00% |
Entia Biosciences Inc | 99.95% |